StockClub
MCRBSeres Therapeutics, Inc.$ --
Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

MCRB

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
1M USD
-

Operating Income

bar_chart
-94M USD
YoY +22.5%

Net Income

verified
6M USD
YoY +103.9%

EPS

pie_chart
0.64USD
YoY +103.4%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2026
Net Income Progress28.2%On Track
Revenue Progress358,000
Revenue Forecast25M
Net Income Progress-19.9M
Net Income Forecast-70.5M

Income Statement Details

Item
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
1
4
-3
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
49
0
39
95
-94
Interest expense
Income before tax
Income tax expense
Net income
0
6
0
6

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.